# A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors

> **NCT01315431** · PHASE1 · UNKNOWN · sponsor: **Genta Incorporated** · enrollment: 9 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** Tesetaxel plus capecitabine

## Key facts

- **NCT ID:** NCT01315431
- **Lead sponsor:** Genta Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2012-08
- **Final completion:** 2012-10
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2012-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01315431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01315431, "A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01315431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*